# Encompass Health Corporation (EHC) stock price

URL: https://funkfolio.com/stock/EHC

> Encompass Health Corporation (EHC) trades at $139.64, is worth $13.7B, is priced at 22.3× earnings and scores 58/100. Valuation, financials and signals.

---

## Encompass Health Corporation (EHC)

Encompass Health Corporation (EHC) is a healthcare company (medical care facilities) based in the United States. The share price is $139.64, down 1.74% on the day, which values the company at $13.7B. Price as of 17 Nov 2026, 19:12 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $139.64 −1.74% today
- **Market value:** $13.7B
- **P/E ratio:** 22.3× last 12 months
- **Forward P/E:** 20.3×
- **Dividend yield:** 0.55%
- **Funk Score:** 58/100
- **Against its own history:** Well above its usual price usual price $97.00
- **200-week average:** $93.48 49% above

Figures as of 17 Nov 2026, 19:12 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Encompass Health Corporation in more detail

EHC trades at 22.3× its last twelve months' earnings, 20.3× next year's expected earnings, 2.2× sales. Measured against its own history, the price is 44% above what its usual multiples would imply ($97.00) — well above its usual price. It sits 49% above its 200-week average of $93.48.

Over the last five fiscal years Encompass Health Corporation has compounded revenue 10.7% a year, earnings per share 14.2% a year, free cash flow 7.1% a year. Its Funk Score is 58 out of 100 (financial strength 6.1, profitability 6.8, growth 6.6, value 3.9, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

4 of the superinvestors tracked here hold EHC, including Brandon Haley (0.2% of the portfolio), Fred DiSanto (0.2% of the portfolio), Ken Griffin (0.1% of the portfolio).

### Superinvestors holding EHC

4 of the investors tracked here report a position in their latest 13F filing.

- [Brandon Haley Holocene Advisors](https://funkfolio.com/gurus/brandon-haley) 0.23% of portfolio · $98.8M · added · Q2 2026
- [Fred DiSanto Ancora](https://funkfolio.com/gurus/fred-disanto) 0.21% of portfolio · $10.6M · added · Q2 2026
- [Ken Griffin Citadel Advisors](https://funkfolio.com/gurus/ken-griffin) 0.15% of portfolio · $259.1M · added · Q2 2026
- [Jensen team Jensen Investment Management](https://funkfolio.com/gurus/jensen-investment) 0.13% of portfolio · $4.1M · trimmed · Q3 2026

### Health Care companies of similar size

- [Solventum SOLV](https://funkfolio.com/stock/SOLV)
- [BridgeBio Pharma BBIO](https://funkfolio.com/stock/BBIO)
- [Summit Therapeutics SMMT](https://funkfolio.com/stock/SMMT)
- [Glaukos GKOS](https://funkfolio.com/stock/GKOS)
- [BrightSpring Health Services BTSG](https://funkfolio.com/stock/BTSG)
- [Baxter International BAX](https://funkfolio.com/stock/BAX)
- [Elanco Animal Health ELAN](https://funkfolio.com/stock/ELAN)
- [Smith & Nephew SNN](https://funkfolio.com/stock/SNN)
- [Penumbra PEN](https://funkfolio.com/stock/PEN)
- [Dr. Reddy's Laboratories RDY](https://funkfolio.com/stock/RDY)
- [Align Technology ALGN](https://funkfolio.com/stock/ALGN)
- [Cooper Companies COO](https://funkfolio.com/stock/COO)

Side by side: [EHC vs BTSG (Encompass Health Corporation vs BrightSpring Health Services)](https://funkfolio.com/compare/btsg-vs-ehc) [EHC vs BAX (Encompass Health Corporation vs Baxter International)](https://funkfolio.com/compare/bax-vs-ehc) [EHC vs ELAN (Encompass Health Corporation vs Elanco Animal Health)](https://funkfolio.com/compare/ehc-vs-elan) [EHC vs GKOS (Encompass Health Corporation vs Glaukos)](https://funkfolio.com/compare/ehc-vs-gkos) [EHC vs SNN (Encompass Health Corporation vs Smith & Nephew)](https://funkfolio.com/compare/ehc-vs-snn)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Encompass Health Corporation (EHC): questions and answers

**What is EHC's P/E ratio?**

Encompass Health Corporation trades at 22.3× its last twelve months' earnings and 20.3× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 2.5× to 24.4×, with a median of 17.8×.

**What is EHC's PEG ratio?**

Encompass Health Corporation's PEG ratio is 0.41 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Encompass Health Corporation's market cap?**

Encompass Health Corporation is valued at $13.7B at a share price of $139.64.

**Is EHC overvalued or undervalued?**

Against its own history, EHC is well above its usual price: the price is 44% above the $97.00 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is EHC above its 200-week moving average?**

Yes. EHC is 49.4% above its 200-week average of $93.48. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Encompass Health Corporation growing?**

Over the last five fiscal years Encompass Health Corporation's revenue grew 10.7% a year and its earnings per share 14.2% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Encompass Health Corporation (EHC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/EHC

Underlying data: Yahoo Finance; company filings with the SEC.
